Back to results
US 2014/0030230 A1Published application
Avian metapneumovirus in oncolysis
OwnerCarla Christina Schrierinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to live avian metapneiunovirus (AMPV) for use in cancer therapy and to pharmaceutical compositions for use in cancer therapy comprising a cytotoxic amount of live avian metapneumovims (AMPV) and a pharmaceutically acceptable carrier
Claims20
A method of treating cancer in a mammal comprising administering a live avian metapneumovirus (AMPV) to said mammal.
A method of treating cancer in a mammal comprising administering a pharmaceutical composition comprising a cytotoxic amount of live avian metapneumovirus (AMPV) and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.